Bevacizumab in advanced lung cancer: in search of the right drug for the right patient.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 30, 2010
has subject area
- Angiogenesis Inhibitors (MeSH)
- Antibodies, Monoclonal (MeSH)
- Antibodies, Monoclonal, Humanized (MeSH)
- Bevacizumab (MeSH)
- Humans (MeSH)
- Lung Neoplasms (MeSH)
- Precision Medicine (MeSH)
- Vascular Endothelial Growth Factor A (MeSH)
published in
- Oncology Journal